Background illustration for clinical trials search

Paid Clinical Trials Seattle

Discover 1,443 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Seattle WA, Tacoma WA, Olympia WA, Salem OR, Spokane WA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Seattle WA, Edmonds WA, San Francisco CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone

for
Substance-Related Disorders
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 40

Code: NCT00504413

Phase1, Recruiting

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Seattle WA, Edmonds WA, Los Angeles CA, Winnipeg,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05061550

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

for
B-cell Malignancies
Location: Seattle WA, Calgary, La Jolla CA, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06542250

Phase1, Phase2, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for
Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,
Location: Seattle WA, Vancouver, Portland OR, San Francisco CA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

for
Cystic Fibrosis
Location: Seattle WA, Spokane WA, Salt Lake City UT,
Sponsor: Aridis Pharmaceuticals, Inc.

Sex: All

Age: 18 - 49

Code: NCT03669614

Phase1, Phase2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Seattle WA, Vancouver WA, Portland OR, Eugene OR,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase3, Recruiting

Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

for
Endometriosis
Location: Seattle WA, Columbus OH, Norfolk VA, Sarasota FL
Sponsor: Enteris BioPharma Inc.

Sex: Female

Age: 18 - 49

Code: NCT05096065

Phase2, Recruiting

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

for
Arthritis, Psoriatic
Location: Seattle WA, Portland OR, Calgary, Thousand Oaks CA,
Sponsor: MoonLake Immunotherapeutics AG

Sex: All

Age: 18+

Code: NCT06641089

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Seattle WA, Portland OR, Reno NV, Walnut Creek CA,
Sponsor: Kallyope Inc.

Sex: All

Age: 18 - 70+

Code: NCT07645924

Phase3, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Seattle WA, Edmonds WA, Issaquah WA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase3, Recruiting

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

for
Multiple Sclerosis
Location: Seattle WA, Milwaukee WI, St Louis MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 60

Code: NCT07224373

Phase1, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Seattle WA, Portland OR, Billings MT, Las Vegas NV,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase3, Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Acute Migraine
Location: Seattle WA, Portland OR, Reno NV, Walnut Creek CA,
Sponsor: Kallyope Inc.

Sex: All

Age: 18+

Code: NCT07674654

Phase3, Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Seattle WA, Vancouver, Portland OR, Calgary, Edmonton,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase3, Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

for
Severe Hypertriglyceridemia
Location: Seattle WA, Santa Clarita CA, Los Angeles CA,
Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06880770

Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Seattle WA, Redmond WA, Renton WA, Tacoma WA, Victoria,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Seattle WA, Vancouver, Portland OR, Spokane WA, Calgary,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07052903

Phase3, Recruiting

As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.

Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.

Why choose Seattle for clinical trials?

For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.

By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.

Common conditions studied in Seattle

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Seattle